ライフサイエンスコーパス: clinical immunology

1 in Allergy (European Journal of Allergy and Clinical Immunology).

2 ) molecules is widely used in both basic and clinical immunology.

3 ortant implications for both fundamental and clinical immunology.

4 antibody engineering, antigen docking and in clinical immunology.

5 genetic disorders, transforming the field of clinical immunology.

6 Group of the European Academy of Allergy and Clinical Immunology.

7 as how research genomics is integrated into clinical immunology.

8 roup and the European Academy of Allergy and Clinical Immunology.

9 ical factor limiting their broad adoption in clinical immunology.

10 ble and would greatly impact fundamental and clinical immunology.

11 Group of the European Academy of Allergy and Clinical Immunology.

12 ehalf of the European Academy of Allergy and Clinical Immunology.

13 ction of the European Academy of Allergy and Clinical Immunology.

14 of Japanese Society of Pediatric Allergy and Clinical Immunology.

15 Education and training in Allergy and Clinical Immunology (A/I) are characterized by a great v

16 is a recently emerging field in allergy and clinical immunology, a better understanding of the metab

17 her with the European Academy of Allergy and Clinical Immunology advocates the status of a full speci

18 force of the European Academy of Allergy and Clinical Immunology, aimed to assess the current practic

19 The European Academy of Allergy and Clinical Immunology Anaphylaxis multidisciplinary Task F

20 ction of the European Academy of Allergy and Clinical Immunology and aims to provide a unified endosc

21 Asthma & Immunology, Australasian Society of Clinical Immunology and Allergy, Canadian Society of All

22 he contributions of x-ray crystallography to clinical immunology and allergy, focusing on new molecul

23 chieved lately, particularly in the field of clinical immunology and allergy.

24 hed since 2015 in the Journal of Allergy and Clinical Immunology and other high-impact journals was p

25 iatives, the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy,

26 between the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy,

27 ffort of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy,

28 ative of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy,

29 nized by the European Academy of Allergy and Clinical Immunology and the European Federation of Aller

30 a Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI), has spent tremendous effo

31 n-makers in the field of allergy, asthma and clinical Immunology around an open debate on contemporar

32 Basic and clinical immunology articles published in the Journal in

33 ehalf of the European Academy of Allergy and Clinical Immunology as part of their Guidelines for Food

34 We reviewed advances in clinical immunology, as well as new approaches of whole-

35 ittee of the British Society for Allergy and Clinical Immunology (BSACI) and a committee of experts a

36 ittee of the British Society for Allergy and Clinical Immunology (BSACI) and an expert panel have pre

37 SOCC) of the British Society for Allergy and Clinical Immunology (BSACI) and is intended for allergis

38 SOCC) of the British Society for Allergy and Clinical Immunology (BSACI) and is intended for clinicia

39 distributed to British Society for Allergy & Clinical Immunology (BSACI) members to capture clinician

40 The British Society for Allergy and Clinical Immunology (BSACI) Registry for Immunotherapy (

41 The British Society of Allergy and Clinical Immunology (BSACI) Standards of Care Committee

42 RCPCH and the British Society of Allergy and Clinical Immunology (BSACI) to define service priorities

43 tions of the British Society for Allergy and Clinical Immunology (BSACI), the Association of Anaesthe

44 ducted by the British Society of Allergy and Clinical Immunology (BSACI).

45 ittee of the British Society for Allergy and Clinical Immunology (BSACI).

46 lergy of the European Academy of Allergy and Clinical Immunology by means of a nonsystematic review o

47 s the EAACI (European Academy of Allergy and Clinical Immunology) Combined Symptom and Medication Sco

48 nected public health screening community and clinical immunology community, these SCID NBS deliberati

49 ented at the European Academy of Allergy and Clinical Immunology Congress 2019, provides information

50 The European Academy of Allergy and Clinical Immunology created a task force to assess the s

51 re, we present a multiparametric analysis of clinical immunology data collected during the 2017-2018

52 Here, we present clinical immunology data obtained in the field during th

53 ) and EAACI (European Academy of Allergy and Clinical Immunology) developed a Task Force aimed at pro

54 ction of the European Academy of Allergy and Clinical Immunology, discusses the main cholinergic path

55 ology" section of the Journal of Allergy and Clinical Immunology during 2012 enhanced our knowledge o

56 e members of European Academy of Allergy and Clinical Immunology (EAACI) (individuals) and World Alle

57 paper of the European Academy of Allergy and Clinical Immunology (EAACI) agrees with these recommenda

58 erefore, the European Academy of Allergy and Clinical Immunology (EAACI) aimed to analyze the situati

59 ative of the European Academy of Allergy and Clinical Immunology (EAACI) aimed to propose definitions

60 rated by the European Academy of Allergy and Clinical Immunology (EAACI) and American Academy of Alle

61 ollaborative European Academy of Allergy and Clinical Immunology (EAACI) and European Association of

62 between the European Academy of Allergy and Clinical Immunology (EAACI) and the American Academy of

63 he vision of European Academy of Allergy and Clinical Immunology (EAACI) and the Union of European Me

64 The European Academy of Allergy and Clinical Immunology (EAACI) assembled an expert panel un

65 ntly planned European Academy of Allergy and Clinical Immunology (EAACI) clinical practice guideline

66 ivity by the European Academy of Allergy and Clinical Immunology (EAACI) differentiates between cross

67 urvey of the European Academy of Allergy and Clinical Immunology (EAACI) Drug Allergy Interest Group

68 The European Academy of Allergy and Clinical Immunology (EAACI) established a Task Force to

69 The European Academy of Allergy and Clinical Immunology (EAACI) Food Allergy and Anaphylaxis

70 The current European Academy of Allergy and Clinical Immunology (EAACI) guidelines recommend assessi

71 followed the European Academy of Allergy and Clinical Immunology (EAACI) guidelines.

72 The European Academy of Allergy and Clinical Immunology (EAACI) has produced Guidelines on A

73 (TF) of the European Academy of Allergy and Clinical Immunology (EAACI) Immunotherapy Interest Group

74 Network and European Academy of Allergy and Clinical Immunology (EAACI) Interest Group on Drug Aller

75 The European Academy of Allergy and Clinical Immunology (EAACI) is developing guidelines for

76 (TF) of the European Academy of Allergy and Clinical Immunology (EAACI) is evaluating several outcom

77 The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of develop

78 The European Academy of Allergy and Clinical Immunology (EAACI) is updating the Guidelines o

79 tions of the European Academy of Allergy and Clinical Immunology (EAACI) on pollen season and peak po

80 The European Academy of Allergy and Clinical Immunology (EAACI) organized the first European

81 This European Academy of Allergy and Clinical Immunology (EAACI) position paper provides an i

82 In this European Academy of Allergy and Clinical Immunology (EAACI) Position Paper, the Task For

83 ns" from the European Academy of Allergy and Clinical Immunology (EAACI) present the data from a surv

84 paper by the European Academy of Allergy and Clinical Immunology (EAACI) proposed season definitions

85 In 2014, the European Academy of Allergy and Clinical Immunology (EAACI) published the first systemat

86 rmation, the European Academy of Allergy and Clinical Immunology (EAACI) states its position for the

87 The European Academy of Allergy and Clinical Immunology (EAACI) supports three journals: All

88 oduced by an European Academy of Allergy and Clinical Immunology (EAACI) task force, highlights our c

89 pared by the European Academy of Allergy and Clinical Immunology (EAACI) Taskforce on Anaphylaxis.

90 The European Academy of Allergy and Clinical Immunology (EAACI) therefore initiated a Task F

91 nched by the European Academy of Allergy and Clinical Immunology (EAACI) via e-mail, website, and soc

92 AI), and the European Academy of Allergy and Clinical Immunology (EAACI), and then the American Colle

93 ative of the European Academy of Allergy and Clinical Immunology (EAACI), experts from academia and r

94 ormed by the European Academy of Allergy and Clinical Immunology (EAACI), the American Academy of All

95 oards of the European Academy of Allergy and Clinical Immunology (EAACI), the American Academy of All

96 ction of the European Academy of Allergy and Clinical Immunology (EAACI), the EU-funded network of ex

97 The European Academy of Allergy and Clinical Immunology (EAACI), the European Rhinologic Soc

98 posed by the European Academy of Allergy and Clinical Immunology (EAACI), this review highlights the

99 posed by the European Academy of Allergy and Clinical Immunology (EAACI), was used, which was assesse

100 RIA) and the European Academy of Allergy and Clinical Immunology (EAACI)-on digital biomarkers.

101 eries of the European Academy of Allergy and Clinical Immunology (EAACI).

102 ified by the European Academy of Allergy and Clinical Immunology (EAACI).

103 as European (European Academy of Allergy and Clinical immunology, EAACI, European Respiratory Society

104 and Allergy, Canadian Society of Allergy and Clinical Immunology, European Academy of Allergy and Cli

105 reason, the European Academy of Allergy and Clinical Immunology gave its patronage to a consensus co

106 nternational European Academy of Allergy and Clinical Immunology/Global Allergy and Asthma European N

107 based on the European academy of allergy and clinical immunology grading system.

108 m/Asia Pacific Association of Allergy Asthma Clinical Immunology guideline for the definition, classi

109 This European Academy of Allergy and Clinical Immunology guideline provides recommendations f

110 GA(2)LEN-European Academy of Allergology and Clinical Immunology guidelines and the opinions of 14 pe

111 The European Academy of Allergy and Clinical Immunology has developed a clinical practice gu

112 The European Academy of Allergy and Clinical Immunology has developed a guideline to provide

113 My work on basic and clinical immunology has focused on the regulation of the

114 Group of the European Academy of Allergy and Clinical Immunology has organized a task force to provid

115 ular and cellular underpinnings of basic and clinical immunology has significantly advanced our under

116 Clinical immunology has traditionally relied on accurate

117 Group of the European Academy of Allergy and Clinical Immunology have formed a task force and develop

118 er, from the European Academy of Allergy and Clinical Immunology, highlights the shortcomings of curr

119 t was reported in the Journal of Allergy and Clinical Immunology in 2011, with emphasis on health out

120 In the Journal of Allergy and Clinical Immunology in 2012, research reports related to

121 tatus by the European Academy of Allergy and Clinical Immunology in 2014.

122 loped by the European Academy of Allergy and Clinical Immunology in collaboration with national aller

123 Advances in clinical immunology in the past year included the report

124 ntly developed by The Journal of Allergy and Clinical Immunology: In Practice, Radiology and jointly

125 ergy and the European Academy of Allergy and Clinical Immunology interested in drug allergy participa

126 tive of the European Academy for Allergy and Clinical Immunology is to support breastfeeding in all i

127 Immunology, European Academy of Allergy and Clinical Immunology, Israel Association of Allergy and C

128 mmunology, Israel Association of Allergy and Clinical Immunology, Japanese Society for Allergology, S

129 in the three European Academy of Allergy and Clinical Immunology journals, during the period 2009-201

130 Clinical Immunology Laboratory, Department of Pathology,

131 and the European Academy of Allergology and Clinical Immunology) met several times between 2010 and

132 in AIT, the European Academy of Allergy and Clinical Immunology Methodology Committee recently initi

133 tment of AIDS will not be possible until the clinical immunology of AIDS is understood.

134 enormous amount that is not known about the clinical immunology of AIDS, and the central question re

135 olecular virology still fails to explain the clinical immunology of AIDS.

136 Group of the European Academy of Allergy and Clinical Immunology organized a task force to provide da

137 opic published in the Journal of Allergy and Clinical Immunology over the past decade.

138 This European Academy of Allergy and Clinical Immunology Position Paper responds to this chal

139 ing the 1993 European Academy of Allergy and Clinical Immunology position paper, the 2001 ARIA docume

140 orts to successfully integrate AI into daily clinical immunology practice are still needed.

141 rden, as indicated in Journal of Allergy and Clinical Immunology publications in 2011.

142 thma, as indicated in Journal of Allergy and Clinical Immunology publications in 2012.

143 dren, as indicated in Journal of Allergy and Clinical Immunology publications in 2013 and early 2014.

144 ldren as indicated in Journal of Allergy and Clinical Immunology publications in 2014.

145 In 2014, the European Academy of Allergy and Clinical Immunology published prevalence estimates for f

146 o inform the European Academy of Allergy and Clinical Immunology's (EAACI) anaphylaxis guideline.

147 pared by the European Academy of Allergy and Clinical Immunology's (EAACI) Guidelines for Food Allerg

148 pared by the European Academy of Allergy and Clinical Immunology's (EAACI) Guidelines for Food Allerg

149 pared by the European Academy of Allergy and Clinical Immunology's (EAACI) Taskforce on Prevention an

150 pared by the European Academy of Allergy and Clinical Immunology's (EAACI) Taskforce on Venom Immunot

151 published in the "Mechanisms of allergy and clinical immunology" section of the Journal of Allergy a

152 precipitin were identified from the Oklahoma Clinical Immunology Serum Repository.

153 This method is easily adapted for use in a clinical immunology setting and can be modified for othe

154 applied it to labelling of the Federation of Clinical Immunology Societies Human Immunology Project C

155 undations; Burroughs Wellcome Fund CAMS; the Clinical Immunology Society; the American Academy of All

156 may have immediate application for basic and clinical immunology studies pertaining to modulation of

157 loped by the European Academy of Allergy and Clinical Immunology systematic reviews (SR) assessed usi

158 The European Academy of Allergy & Clinical Immunology Task Force on Anti-infectives in Ast

159 The European Academy of Allergy & Clinical Immunology Task Force on Biomarkers in Asthma w

160 s field, the European Academy of Allergy and Clinical Immunology Task Force on Diet and Immunomodulat

161 rts from the European Academy of Allergy and Clinical Immunology Task Force on NSAIDs Hypersensitivit

162 This European Academy of Allergy and Clinical Immunology task force was therefore established

163 pared by the European Academy of Allergy and Clinical Immunology Taskforce on Rhinitis in Children, a

164 In clinical immunology, they are recognized for their centr

165 dies published in the Journal of Allergy and Clinical Immunology this year provided new insights into

166 ve engaged experts in both basic biology and clinical immunology to capture the worldwide experience

167 logy and the European Academy of Allergy and Clinical Immunology to provide shared evidence-based rec

168 Group of the European Academy of Allergy and Clinical Immunology undertook an educational needs surve

169 mittee of the British Society of Allergy and Clinical Immunology, using accredited methods.

170 score of the European Academy of Allergy and Clinical Immunology was used.

171 is theme issue of the Journal of Allergy and Clinical Immunology, we address what is known and not kn

172 icals of the European Academy of Allergy and Clinical Immunology, we review biologicals that are curr

173 Immunology; European Academy of Allergy and Clinical Immunology; World Allergy Organization; and Ame